Navigation Links
Sinovac Reports Top-Line Preliminary Phase II Results of Pandemic Influenza (H5N1) Whole Viron Vaccine
Date:12/24/2007

BEIJING, Dec. 24 /Xinhua-PRNewswire/ -- Sinovac Biotech Ltd. (Amex: SVA), a leading provider of vaccines in China, today announced positive top-line results of completed Phase II clinical trial of its pandemic influenza (H5N1) whole viron inactivated vaccine. The stratified, randomized, double-blind trial of the vaccine was designed to assess the safety and immunogenicity of the vaccine.

Sinovac received approval from the China State Food and Drug Administration (SFDA) in April 2007 to conduct Phase Ib and II trials of the H5N1 whole viron vaccine and Phase I and Phase II trials of the H5N1 split vaccine.

The Phase II trial of the H5N1 whole viron inactivated vaccine was conducted by Beijing Centers for Disease Control and Prevention. It included 402 volunteers, between the ages of 18 and 60, who were each vaccinated with two doses of 5 ug, 10 ug or 15 ug. The preliminary results of the trials suggested that each of the three dosages can induce varying degrees of immune response. In particular, the anti-HI seroconversion rate, the increasing GMT and protection rate of the H5N1 whole viron inactivated vaccines for the 10ug and 15ug dosages reached the EMEA evaluation standards of seasonal flu vaccines, which is an indication of good immunogenicity of the vaccine. The trial result did not show any serious adverse reaction among volunteers, suggesting the vaccine's good safety profile.

In addition, Sinovac recently completed the phase I clinical trial of the split H5N1 vaccine. The result of vaccinations on children, adults and elderly with candidate vaccines of different dosage indicated that the split H5N1 vaccine is safe for human use.

Mr. Weidong Yin, Chairman, President and CEO, stated, "We are very pleased with the achievements of our team that led to the development of a pandemic influenza vaccine. After Phase II clinical trials of the whole viron H5N1 vaccine, the vaccine dosages and schedule can now be determined. This accomp
'/>"/>

SOURCE Sinovac Biotech Ltd.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Sinovac Announces Postponement of Annual General Meeting
2. Sinovac Requests Extension for Annual Shareholders Meeting
3. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
4. QMed, Inc. Reports July Medicare SNP Enrollments
5. Phlo Affiliate Reports Expanded Coverage to Oregon Border
6. Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results
7. Dragon Pharmaceutical Reports Growth in Sales and Profits during Second Quarter of 2007
8. Carrington Reports Second Quarter 2007 Results
9. Avitar Reports Third Quarter Financial Results for Fiscal 2007
10. Response Genetics Reports Second Quarter 2007 Financial Results
11. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/7/2008)...ected to aid drug discovery by allowing for the ra...gle reaction, ST. LOUIS, Oct. 7 /PRNewswire-First...o announce that it has signed an exclusive licensi...bana-Champaign allowing,Sigma-Aldrich to offer res...ogates for use in Suzuki-Miyaura coupling to resea...
(Date:10/7/2008)...s to focus on new patient data supporting the Ross...ynerGraft processed human heart .../- CryoLife, Inc. (NYSE: C...ocessing company, announced today,that cardiovascu...e in the,Ross Summit 2008, a two-day surgical cong...
(Date:10/7/2008)...Institutes of Health, The Infectious Disease Resea...Launch and Board of Advisors, SEATTLE, Oct. 7 /PR...,Initiative today announced its first acquisition ...osis (TB) drug candidates. Agreements were reached...nd the Microbial Chemistry,Research Foundation (MC...
(Date:10/7/2008)... Oct. 7 /- BioEnergy International, L...r and manufacturer of,next-generation, renewable b...f Norman R. Augustine to its Board of Advisors eff...f distinguished leadership and innovation,at the h...g in his role as,Chairman and Chief Executive Offi...
Breaking Biology Technology:Sigma-Aldrich and the University of Illinois Offer New Boronic Acid Surrogates to Researchers Worldwide Through Licensing Agreement 2Sigma-Aldrich and the University of Illinois Offer New Boronic Acid Surrogates to Researchers Worldwide Through Licensing Agreement 3CryoLife Hosts Worldwide Surgical Congress for the Ross Procedure 2CryoLife Hosts Worldwide Surgical Congress for the Ross Procedure 3CryoLife Hosts Worldwide Surgical Congress for the Ross Procedure 4Update: The Lilly TB Drug Discovery Initiative Begins Work on New Compounds to Fill Early-Stage TB Drug Pipeline 2Update: The Lilly TB Drug Discovery Initiative Begins Work on New Compounds to Fill Early-Stage TB Drug Pipeline 3Update: The Lilly TB Drug Discovery Initiative Begins Work on New Compounds to Fill Early-Stage TB Drug Pipeline 4Update: The Lilly TB Drug Discovery Initiative Begins Work on New Compounds to Fill Early-Stage TB Drug Pipeline 5BioEnergy International, LLC Announces Norman R. Augustine to Join Advisory Board 2BioEnergy International, LLC Announces Norman R. Augustine to Join Advisory Board 3
... - Last week Gov. Jim Doyle announced a new eHealt...l work to further the adoption of electronic medic... has yet to harness the power of information techn...re system - patient treatment," Doyle said in a st...ealthcare costs are unnecessary or redundant. "Thi...
... Thomas Edison invented the electric light, the ce...,000 patents, but his effort to extract low-grade ...d was dubbed Edisons Folly in the late 1800s. , ,S...ompany he helped to create. Dean Kamen, the creato...0 patents, jokes that his biggest failure is that ...
... GE Healthcare announced today that Rockwood ...ilities in the Spokane, Washington area, has purch...products. , ,One of the new technologies the clini... allow patients to schedule appointments, update t...ically. The patient can take an active role in upl...
...ays low prices. When it comes to consumer goods, A...shop product selection and fanatical commitment to...let going. We like our stuff cheap, and Wal-Mart i...ericans hate to love is getting loads of unfavorab...e successfully derailed its growth plans in certai...
Other Biology Technology:Wisconsin pushes for adoption of electronic health records 2Embracing failure is a necessary step for successful entrepreneurs 2Embracing failure is a necessary step for successful entrepreneurs 3Wal-Mart: How low can you go? 2Wal-Mart: How low can you go? 3Wal-Mart: How low can you go? 4
(Date:10/7/2008)...logy at the University of Minnesota, has been name...r Biology. Tilman will receive a medal, a $100,000...an in a ceremony in Tokyo on Dec. 8. Following the...a scientific symposium. , The award, which is o...receive, is given to one individual in a different...
(Date:10/7/2008)...stitute of Biological Sciences (AIBS) and the Nati...convene a special symposium and workshop for educa...rs (NABT) conference in Memphis, TN. The special ...ach year,s NABT conference, provides classroom tea...ternationally recognized evolutionary biology scho...
(Date:10/7/2008)...s characterized a mechanism that allows for asymme... tracking chromosome movement in live mouse oocyte...t to their vicinity a protein called formin-2. Thi... of the cytoplasm a requirement for embryonic dev...hter cell (called a polar body) resulting from the...
(Date:10/7/2008)...olleagues in France have identified a gene variant...m disorder called sinus node disease. Also known a...ximately one in 600 heart patients older than 65 a...rmanent pacemaker placements in the United States....are, the study provides insight into cellular mech...
Breaking Biology News(10 mins):Minnesota ecology professor wins international award for biodiversity and biofuels research 2Illuminating biology: An evolutionary perspective 2Illuminating biology: An evolutionary perspective 3Illuminating biology: An evolutionary perspective 4Study provides insight on a common heart rhythm disorder 2Study provides insight on a common heart rhythm disorder 3Healthy Interactions and Merck Announce Further Collaboration to Transform Diabetes Education in the U S 21134 1Healthy Interactions and Merck Announce Further Collaboration to Transform Diabetes Education in the U S 21134 2Healthy Interactions and Merck Announce Further Collaboration to Transform Diabetes Education in the U S 21134 3Healthy Interactions and Merck Announce Further Collaboration to Transform Diabetes Education in the U S 21134 4The febit science lounge presents 3A Webinar About Role of Non Protein Coding RNA in Human Genome Set for 11 a m EDT on June 12 21132 1The febit science lounge presents 3A Webinar About Role of Non Protein Coding RNA in Human Genome Set for 11 a m EDT on June 12 21132 2NeurogesX to Present at the Seventh Annual Needham 26 Company Biotechnology and Medical Technology Conference 21130 1NeurogesX to Present at the Seventh Annual Needham 26 Company Biotechnology and Medical Technology Conference 21130 2NeurogesX to Present at the Seventh Annual Needham 26 Company Biotechnology and Medical Technology Conference 21130 3CSCs DynPort Vaccine Company to Continue Plague Vaccine Development 21128 1CSCs DynPort Vaccine Company to Continue Plague Vaccine Development 21128 2CSCs DynPort Vaccine Company to Continue Plague Vaccine Development 21128 3
... of eastern Suriname discovered 24 species believe...escent purple markings and other amphibians, fish ...oday, the findings from a 2005 expedition led by C...am (RAP) and a follow-up survey in 2006 demonstrat...uriname’s rainforest to assess the need to conserv...
...ng dormant bacterial spores, researchers have reve...erations of spore coat and germ cell wall that acc...tive cell. , When starved of nutrients Bacillus (r...etic, biochemical and structural events that resul.... They can remain dormant for extended periods and...
...one’s stomach before and after a rather decadent m...nstruction of the cross-section of a virus, before...The virus, phi29, has a tiny motor that pumps its ...y process. The potential energy of the tightly co...l into the bacterial cells it infects. Now a team...
...ter their metabolism and “hibernate” to conserve e...s to treat human obesity and metabolic disorders, ...und. , The starvation-fighting effects of the ho... are described for the first time in a study appea..., triggered in starving mice by a specific cellula...
Other Biology News:Researchers find 24 species believed new to science in Suriname rainforest 2Researchers track how spores break out of dormant state 2Hormone helps mice 'hibernate,' survive starvation 2
Agarase cleaves agarose to neoagaro-oligosaccharides, and is used for,quantitative, gentle recovery of DNA from low melting point agarose.
Form: Ready to use Applications: ELISA
Request Info
Form: Concentrated Applications: ELISA
Biology Products: